PANACEA BIOTEC
Quarterly Results Analysis [Dec2023]
PANACEA BIOTEC Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 Audited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 Audited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹151 Cr | ₹143 Cr | ₹129 Cr | ₹129 Cr | ₹115 Cr | ₹105 Cr | ₹111 Cr | ₹141 Cr |
Expenses | ₹151 Cr | ₹147 Cr | ₹140 Cr | ₹135 Cr | ₹124 Cr | ₹109 Cr | ₹191 Cr | ₹171 Cr |
Operating Income | ₹0 Cr | ₹-4 Cr | ₹-10 Cr | ₹-6 Cr | ₹-9 Cr | ₹-4 Cr | ₹-80 Cr | ₹-30 Cr |
Other Income | ₹6 Cr | ₹3 Cr | ₹6 Cr | ₹15 Cr | ₹14 Cr | ₹10 Cr | ₹12 Cr | ₹4 Cr |
Interest | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹31 Cr |
Depreciation | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹11 Cr |
Profit Before Tax | ₹-2 Cr | ₹-8 Cr | ₹13 Cr | ₹18 Cr | ₹22 Cr | ₹23 Cr | ₹-51 Cr | ₹1,608 Cr |
Profit After Tax | ₹-2 Cr | ₹-8 Cr | ₹11 Cr | ₹-13 Cr | ₹19 Cr | ₹16 Cr | ₹-56 Cr | ₹1,237 Cr |
EPS | ₹-0.36 | ₹-1.35 | ₹1.79 | ₹-2.07 | ₹3.16 | ₹2.56 | ₹-9.16 | ₹201.87 |
Industry Peers & Returns | 1W | 1M | 1Y |
PANACEA BIOTEC | -4.4% | -7.3% | 10.5% |
SUN PHARMACEUTICAL INDUSTRIES | -1.5% | -5.8% | 55.3% |
CIPLA | -5.9% | -8.4% | 45.7% |
DR REDDYS LABORATORIES | -6.1% | -4.1% | 19.8% |
ZYDUS LIFESCIENCES | -3.7% | -1.8% | 84.3% |
DIVIS LABORATORIES | -4.3% | -0.1% | 15.3% |
MANKIND PHARMA | -2% | -5.1% | NA |
TORRENT PHARMACEUTICALS | -4.2% | 0.1% | 51.3% |
LUPIN | -4.2% | -0.2% | 116.4% |
PANACEA BIOTEC Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 5.23 % |
Y-o-Y | 30.64 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹151 Cr | 5.23 | |
Sep2023 | ₹143 Cr | 10.71 | |
Jun2023 | ₹129 Cr | 0.20 | |
Mar2023 | ₹129 Cr | 11.92 | |
Dec2022 | ₹115 Cr | 9.59 | |
Sep2022 | ₹105 Cr | -5.04 | |
Jun2022 | ₹111 Cr | -21.34 | |
Mar2022 | ₹141 Cr | - |
PANACEA BIOTEC Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹0 Cr | Negative | |
Sep2023 | ₹-4 Cr | Negative | |
Jun2023 | ₹-10 Cr | Negative | |
Mar2023 | ₹-6 Cr | Negative | |
Dec2022 | ₹-9 Cr | Negative | |
Sep2022 | ₹-4 Cr | Negative | |
Jun2022 | ₹-80 Cr | Negative | |
Mar2022 | ₹-30 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | -0.1% | Negative | |
Sep2023 | -2.49% | Negative | |
Jun2023 | -7.98% | Negative | |
Mar2023 | -4.4% | Negative | |
Dec2022 | -7.5% | Negative | |
Sep2022 | -3.65% | Negative | |
Jun2022 | -72.1% | Negative | |
Mar2022 | -21.45% | - |
PANACEA BIOTEC Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹-2 Cr | Negative | |
Sep2023 | ₹-8 Cr | Negative | |
Jun2023 | ₹11 Cr | Positive | |
Mar2023 | ₹-13 Cr | Negative | |
Dec2022 | ₹19 Cr | 23.38 | |
Sep2022 | ₹16 Cr | Positive | |
Jun2022 | ₹-56 Cr | Negative | |
Mar2022 | ₹1,237 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | -1.46 % | Negative | |
Sep2023 | -5.8 % | Negative | |
Jun2023 | 8.5 % | Positive | |
Mar2023 | -9.83 % | Negative | |
Dec2022 | 16.81 % | 12.52 | |
Sep2022 | 14.94 % | Positive | |
Jun2022 | -50.71 % | Negative | |
Mar2022 | 879.32 % | - |
PANACEA BIOTEC Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹-0.36 | Negative | |
Sep2023 | ₹-1.35 | Negative | |
Jun2023 | ₹1.79 | Positive | |
Mar2023 | ₹-2.07 | Negative | |
Dec2022 | ₹3.16 | 23.44 | |
Sep2022 | ₹2.56 | Positive | |
Jun2022 | ₹-9.16 | Negative | |
Mar2022 | ₹201.87 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD